Description
On behalf of Pharmaceutical Resource Technology, Inc., we welcome you to invest in the company as a shareholder. While we are making the offering to sell our shares for cash, there are benefits and risks inherent in the offering that prospective shareholders are advised to evaluate carefully before investing their money.
Prior to this Offering, no public market has existed for the common stock of Pharmaceutical Resource Technology, Inc. Upon completion of this Offering, we will attempt to have the shares quoted on the OTC Markets Group, Inc. There is no assurance that the Shares will ever be quoted on the OTC. To be quoted on the OTC, a market maker must apply to make a market in our common stock. As of the date of this Offering, we have not made any arrangement with any market makers to quote our shares. In this private offering we, “Pharmaceutical Resource Technology, Inc” are offering 300,000,000 shares of our common stock. The offering is being made on a self-underwritten, “best efforts” basis. The minimum number of shares required to be purchased by each investor is USD1000. The shares offered by the Company will be sold on our behalf by our own underwriter of this offering. We will not receive any commissions or proceeds for selling the shares on our behalf. All of the shares being offered for sale by the Company will be sold at a fixed price of US$0.50 per share for the duration of the Offering. Assuming all of the 300,000,000 shares being offered by the Company are sold, the Company will receive US$150,000,000 in net proceeds. Assuming 150,000,000 shares (50%) being offered by the Company are sold, the Company will receive US$75,000,000 in net proceeds. We seek to raise USD25 million from the shares being offered by the Company and any funds received will be immediately available to us. There is no guarantee that we will sell any of the shares being offered in this offering. Additionally, there is no guarantee that this Offering will successfully raise enough funds to institute our Company's business operation and expansion plan. Additionally, there is no guarantee that a public market will ever develop and you may be unable to sell your shares. This private offering will terminate upon the earliest of (i) such time when all of the common stock offered has been sold or
(ii) 365 days from the effective date of this prospectus unless extended by our Board of Directors for an additional 90 days.
We may however, at any time and for any reason terminate the offering. The proceeds from the sale of the shares sold on behalf of the Company will be placed directly into the Company’s account; any investor who purchases shares will have no assurance that any monies, beside their own, will be subscribed to the prospectus. All proceeds from the sale of the shares are non-refundable, except as may be required by applicable laws. You should rely only on the information contained in our website and the information we have referred you to. We have not authorized any person to provide you with any information about this Offering, the Company, or the shares of our Common Stock offered hereby that is different from the information included in this Offering. If anyone provides you with different information, you should not rely on it.
Singapore 
